Cargando…
Discontinuation of rLH two days before hCG may increase the number of oocytes retrieved in IVF
BACKGROUND: Administration of recombinant luteinizing hormone (rLH) in controlled ovarian hyperstimulation may benefit a subpopulation of patients. However, late follicular phase administration of high doses of rLH may also reduce the size of the follicular cohort and promote monofollicular developm...
Autores principales: | Spencer, Jessica B, Browne, Aimee S, Copland, Susannah D, Session, Donna R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855615/ https://www.ncbi.nlm.nih.gov/pubmed/20331901 http://dx.doi.org/10.1186/1477-7827-8-29 |
Ejemplares similares
-
Differences in Signal Activation by LH and hCG are Mediated by the LH/CG Receptor’s Extracellular Hinge Region
por: Grzesik, Paul, et al.
Publicado: (2015) -
Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone
por: Canosa, Stefano, et al.
Publicado: (2022) -
Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation
por: Chambers, Anne E, et al.
Publicado: (2011) -
Effects of Elevated Progesterone Levels on the Day of hCG on the Quality of Oocyte and Embryo
por: Woo, Jeesoo, et al.
Publicado: (2022) -
Association between serum estradiol level on the hCG administration day and IVF-ICSI outcome
por: Kara, Mustafa, et al.
Publicado: (2012)